Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RAY Y HACHEM and DIMITRIOS P KONTOYIANNIS.
RAY Y HACHEM
Connection Strength
1.284
DIMITRIOS P KONTOYIANNIS
  1. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015 Mar; 45(3):283-8.
    View in: PubMed
    Score: 0.123
  2. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009 Oct 15; 115(20):4745-52.
    View in: PubMed
    Score: 0.087
  3. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents. 2008 Dec; 32(6):515-8.
    View in: PubMed
    Score: 0.080
  4. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer. 2008 Jun; 112(11):2493-9.
    View in: PubMed
    Score: 0.079
  5. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7.
    View in: PubMed
    Score: 0.078
  6. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006 May 15; 42(10):1398-403.
    View in: PubMed
    Score: 0.068
  7. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7.
    View in: PubMed
    Score: 0.064
  8. Invasive aspergillosis in patients with solid tumors. Cancer. 2004 Nov 15; 101(10):2300-2.
    View in: PubMed
    Score: 0.062
  9. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer. 2004 Oct 01; 101(7):1594-600.
    View in: PubMed
    Score: 0.061
  10. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma. 2004 Jan; 45(1):139-41.
    View in: PubMed
    Score: 0.058
  11. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9.
    View in: PubMed
    Score: 0.058
  12. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9.
    View in: PubMed
    Score: 0.056
  13. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8.
    View in: PubMed
    Score: 0.056
  14. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
    View in: PubMed
    Score: 0.055
  15. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.
    View in: PubMed
    Score: 0.050
  16. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 07; 63(7).
    View in: PubMed
    Score: 0.043
  17. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8.
    View in: PubMed
    Score: 0.025
  18. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011; 16(7):1049-60.
    View in: PubMed
    Score: 0.024
  19. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore). 2010 Jul; 89(4):236-244.
    View in: PubMed
    Score: 0.023
  20. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8.
    View in: PubMed
    Score: 0.019
  21. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.
    View in: PubMed
    Score: 0.017
  22. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer. 2004 Dec 15; 101(12):2859-65.
    View in: PubMed
    Score: 0.016
  23. Multiple-species candidemia in patients with cancer. Cancer. 2004 Oct 15; 101(8):1860-5.
    View in: PubMed
    Score: 0.015
  24. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004 Apr 15; 38(8):1119-27.
    View in: PubMed
    Score: 0.015
  25. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 01; 98(5):1039-47.
    View in: PubMed
    Score: 0.014
  26. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002 Nov; 47(5):659-66.
    View in: PubMed
    Score: 0.013
  27. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):532-7.
    View in: PubMed
    Score: 0.013
  28. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002 Apr 01; 112(5):380-5.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.